img

Global Duck Virus Enteritis Vaccine Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Duck Virus Enteritis Vaccine Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Vaccine for Duck Virus Enteritis, A duck enteritis virus- vectored bivalent live vaccine provides fast and complete protection against H5N1 avian influenza virus infection in ducks.
Duck Virus Enteritis Vaccine report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Duck Virus Enteritis Vaccine market is projected to reach US$ 97.9 million in 2029, increasing from US$ 67 million in 2022, with the CAGR of 5.5% during the period of 2024 to 2029. Demand from Duck and Others are the major drivers for the industry.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Duck Virus Enteritis Vaccine market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


Ceva Santé Animale
Chengdu TECBOND Biological
Institute of Animal Health and Veterinary Biologicals
Institute of Veterinary Preventive Medicine
International Duck Research Cooperative
MSD Animal Health (Merck)
Ringpu (Tianjin)Bio-Pharmacy
Veterinary Research Institute
Segment by Type
Live Vaccines
Killed Vaccines

Segment by Application


Duck
Others

Segment by Region


North America
the United States
Canada
Europe
Germany
France
UK
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Duck Virus Enteritis Vaccine market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Duck Virus Enteritis Vaccine, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Duck Virus Enteritis Vaccine industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Duck Virus Enteritis Vaccine in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Duck Virus Enteritis Vaccine introduction, etc. Duck Virus Enteritis Vaccine Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of Duck Virus Enteritis Vaccine market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.

Table of Content

1 Duck Virus Enteritis Vaccine Market Overview
1.1 Duck Virus Enteritis Vaccine Product Overview
1.2 Duck Virus Enteritis Vaccine Market Segment by Type
1.2.1 Live Vaccines
1.2.2 Killed Vaccines
1.3 Global Duck Virus Enteritis Vaccine Market Size by Type
1.3.1 Global Duck Virus Enteritis Vaccine Market Size Overview by Type (2018-2029)
1.3.2 Global Duck Virus Enteritis Vaccine Historic Market Size Review by Type (2018-2024)
1.3.3 Global Duck Virus Enteritis Vaccine Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Duck Virus Enteritis Vaccine Sales Breakdown by Type (2018-2024)
1.4.2 Europe Duck Virus Enteritis Vaccine Sales Breakdown by Type (2018-2024)
1.4.3 Asia-Pacific Duck Virus Enteritis Vaccine Sales Breakdown by Type (2018-2024)
1.4.4 Latin America Duck Virus Enteritis Vaccine Sales Breakdown by Type (2018-2024)
1.4.5 Middle East and Africa Duck Virus Enteritis Vaccine Sales Breakdown by Type (2018-2024)
2 Global Duck Virus Enteritis Vaccine Market Competition by Company
2.1 Global Top Players by Duck Virus Enteritis Vaccine Sales (2018-2024)
2.2 Global Top Players by Duck Virus Enteritis Vaccine Revenue (2018-2024)
2.3 Global Top Players by Duck Virus Enteritis Vaccine Price (2018-2024)
2.4 Global Top Manufacturers Duck Virus Enteritis Vaccine Manufacturing Base Distribution, Sales Area, Product Type
2.5 Duck Virus Enteritis Vaccine Market Competitive Situation and Trends
2.5.1 Duck Virus Enteritis Vaccine Market Concentration Rate (2018-2024)
2.5.2 Global 5 and 10 Largest Manufacturers by Duck Virus Enteritis Vaccine Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Duck Virus Enteritis Vaccine as of 2022)
2.7 Date of Key Manufacturers Enter into Duck Virus Enteritis Vaccine Market
2.8 Key Manufacturers Duck Virus Enteritis Vaccine Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Duck Virus Enteritis Vaccine Status and Outlook by Region
3.1 Global Duck Virus Enteritis Vaccine Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Duck Virus Enteritis Vaccine Historic Market Size by Region
3.2.1 Global Duck Virus Enteritis Vaccine Sales in Volume by Region (2018-2024)
3.2.2 Global Duck Virus Enteritis Vaccine Sales in Value by Region (2018-2024)
3.2.3 Global Duck Virus Enteritis Vaccine Sales (Volume & Value) Price and Gross Margin (2018-2024)
3.3 Global Duck Virus Enteritis Vaccine Forecasted Market Size by Region
3.3.1 Global Duck Virus Enteritis Vaccine Sales in Volume by Region (2024-2029)
3.3.2 Global Duck Virus Enteritis Vaccine Sales in Value by Region (2024-2029)
3.3.3 Global Duck Virus Enteritis Vaccine Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Duck Virus Enteritis Vaccine by Application
4.1 Duck Virus Enteritis Vaccine Market Segment by Application
4.1.1 Duck
4.1.2 Others
4.2 Global Duck Virus Enteritis Vaccine Market Size by Application
4.2.1 Global Duck Virus Enteritis Vaccine Market Size Overview by Application (2018-2029)
4.2.2 Global Duck Virus Enteritis Vaccine Historic Market Size Review by Application (2018-2024)
4.2.3 Global Duck Virus Enteritis Vaccine Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Duck Virus Enteritis Vaccine Sales Breakdown by Application (2018-2024)
4.3.2 Europe Duck Virus Enteritis Vaccine Sales Breakdown by Application (2018-2024)
4.3.3 Asia-Pacific Duck Virus Enteritis Vaccine Sales Breakdown by Application (2018-2024)
4.3.4 Latin America Duck Virus Enteritis Vaccine Sales Breakdown by Application (2018-2024)
4.3.5 Middle East and Africa Duck Virus Enteritis Vaccine Sales Breakdown by Application (2018-2024)
5 North America Duck Virus Enteritis Vaccine by Country
5.1 North America Duck Virus Enteritis Vaccine Historic Market Size by Country
5.1.1 North America Duck Virus Enteritis Vaccine Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Duck Virus Enteritis Vaccine Sales in Volume by Country (2018-2024)
5.1.3 North America Duck Virus Enteritis Vaccine Sales in Value by Country (2018-2024)
5.2 North America Duck Virus Enteritis Vaccine Forecasted Market Size by Country
5.2.1 North America Duck Virus Enteritis Vaccine Sales in Volume by Country (2024-2029)
5.2.2 North America Duck Virus Enteritis Vaccine Sales in Value by Country (2024-2029)
6 Europe Duck Virus Enteritis Vaccine by Country
6.1 Europe Duck Virus Enteritis Vaccine Historic Market Size by Country
6.1.1 Europe Duck Virus Enteritis Vaccine Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Duck Virus Enteritis Vaccine Sales in Volume by Country (2018-2024)
6.1.3 Europe Duck Virus Enteritis Vaccine Sales in Value by Country (2018-2024)
6.2 Europe Duck Virus Enteritis Vaccine Forecasted Market Size by Country
6.2.1 Europe Duck Virus Enteritis Vaccine Sales in Volume by Country (2024-2029)
6.2.2 Europe Duck Virus Enteritis Vaccine Sales in Value by Country (2024-2029)
7 Asia-Pacific Duck Virus Enteritis Vaccine by Region
7.1 Asia-Pacific Duck Virus Enteritis Vaccine Historic Market Size by Region
7.1.1 Asia-Pacific Duck Virus Enteritis Vaccine Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Duck Virus Enteritis Vaccine Sales in Volume by Region (2018-2024)
7.1.3 Asia-Pacific Duck Virus Enteritis Vaccine Sales in Value by Region (2018-2024)
7.2 Asia-Pacific Duck Virus Enteritis Vaccine Forecasted Market Size by Region
7.2.1 Asia-Pacific Duck Virus Enteritis Vaccine Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Duck Virus Enteritis Vaccine Sales in Value by Region (2024-2029)
8 Latin America Duck Virus Enteritis Vaccine by Country
8.1 Latin America Duck Virus Enteritis Vaccine Historic Market Size by Country
8.1.1 Latin America Duck Virus Enteritis Vaccine Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Duck Virus Enteritis Vaccine Sales in Volume by Country (2018-2024)
8.1.3 Latin America Duck Virus Enteritis Vaccine Sales in Value by Country (2018-2024)
8.2 Latin America Duck Virus Enteritis Vaccine Forecasted Market Size by Country
8.2.1 Latin America Duck Virus Enteritis Vaccine Sales in Volume by Country (2024-2029)
8.2.2 Latin America Duck Virus Enteritis Vaccine Sales in Value by Country (2024-2029)
9 Middle East and Africa Duck Virus Enteritis Vaccine by Country
9.1 Middle East and Africa Duck Virus Enteritis Vaccine Historic Market Size by Country
9.1.1 Middle East and Africa Duck Virus Enteritis Vaccine Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Duck Virus Enteritis Vaccine Sales in Volume by Country (2018-2024)
9.1.3 Middle East and Africa Duck Virus Enteritis Vaccine Sales in Value by Country (2018-2024)
9.2 Middle East and Africa Duck Virus Enteritis Vaccine Forecasted Market Size by Country
9.2.1 Middle East and Africa Duck Virus Enteritis Vaccine Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Duck Virus Enteritis Vaccine Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Ceva Santé Animale
10.1.1 Ceva Santé Animale Company Information
10.1.2 Ceva Santé Animale Introduction and Business Overview
10.1.3 Ceva Santé Animale Duck Virus Enteritis Vaccine Sales, Revenue and Gross Margin (2018-2024)
10.1.4 Ceva Santé Animale Duck Virus Enteritis Vaccine Products Offered
10.1.5 Ceva Santé Animale Recent Development
10.2 Chengdu TECBOND Biological
10.2.1 Chengdu TECBOND Biological Company Information
10.2.2 Chengdu TECBOND Biological Introduction and Business Overview
10.2.3 Chengdu TECBOND Biological Duck Virus Enteritis Vaccine Sales, Revenue and Gross Margin (2018-2024)
10.2.4 Chengdu TECBOND Biological Duck Virus Enteritis Vaccine Products Offered
10.2.5 Chengdu TECBOND Biological Recent Development
10.3 Institute of Animal Health and Veterinary Biologicals
10.3.1 Institute of Animal Health and Veterinary Biologicals Company Information
10.3.2 Institute of Animal Health and Veterinary Biologicals Introduction and Business Overview
10.3.3 Institute of Animal Health and Veterinary Biologicals Duck Virus Enteritis Vaccine Sales, Revenue and Gross Margin (2018-2024)
10.3.4 Institute of Animal Health and Veterinary Biologicals Duck Virus Enteritis Vaccine Products Offered
10.3.5 Institute of Animal Health and Veterinary Biologicals Recent Development
10.4 Institute of Veterinary Preventive Medicine
10.4.1 Institute of Veterinary Preventive Medicine Company Information
10.4.2 Institute of Veterinary Preventive Medicine Introduction and Business Overview
10.4.3 Institute of Veterinary Preventive Medicine Duck Virus Enteritis Vaccine Sales, Revenue and Gross Margin (2018-2024)
10.4.4 Institute of Veterinary Preventive Medicine Duck Virus Enteritis Vaccine Products Offered
10.4.5 Institute of Veterinary Preventive Medicine Recent Development
10.5 International Duck Research Cooperative
10.5.1 International Duck Research Cooperative Company Information
10.5.2 International Duck Research Cooperative Introduction and Business Overview
10.5.3 International Duck Research Cooperative Duck Virus Enteritis Vaccine Sales, Revenue and Gross Margin (2018-2024)
10.5.4 International Duck Research Cooperative Duck Virus Enteritis Vaccine Products Offered
10.5.5 International Duck Research Cooperative Recent Development
10.6 MSD Animal Health (Merck)
10.6.1 MSD Animal Health (Merck) Company Information
10.6.2 MSD Animal Health (Merck) Introduction and Business Overview
10.6.3 MSD Animal Health (Merck) Duck Virus Enteritis Vaccine Sales, Revenue and Gross Margin (2018-2024)
10.6.4 MSD Animal Health (Merck) Duck Virus Enteritis Vaccine Products Offered
10.6.5 MSD Animal Health (Merck) Recent Development
10.7 Ringpu (Tianjin)Bio-Pharmacy
10.7.1 Ringpu (Tianjin)Bio-Pharmacy Company Information
10.7.2 Ringpu (Tianjin)Bio-Pharmacy Introduction and Business Overview
10.7.3 Ringpu (Tianjin)Bio-Pharmacy Duck Virus Enteritis Vaccine Sales, Revenue and Gross Margin (2018-2024)
10.7.4 Ringpu (Tianjin)Bio-Pharmacy Duck Virus Enteritis Vaccine Products Offered
10.7.5 Ringpu (Tianjin)Bio-Pharmacy Recent Development
10.8 Veterinary Research Institute
10.8.1 Veterinary Research Institute Company Information
10.8.2 Veterinary Research Institute Introduction and Business Overview
10.8.3 Veterinary Research Institute Duck Virus Enteritis Vaccine Sales, Revenue and Gross Margin (2018-2024)
10.8.4 Veterinary Research Institute Duck Virus Enteritis Vaccine Products Offered
10.8.5 Veterinary Research Institute Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Duck Virus Enteritis Vaccine Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Duck Virus Enteritis Vaccine Industrial Chain Analysis
11.4 Duck Virus Enteritis Vaccine Market Dynamics
11.4.1 Duck Virus Enteritis Vaccine Industry Trends
11.4.2 Duck Virus Enteritis Vaccine Market Drivers
11.4.3 Duck Virus Enteritis Vaccine Market Challenges
11.4.4 Duck Virus Enteritis Vaccine Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Duck Virus Enteritis Vaccine Distributors
12.3 Duck Virus Enteritis Vaccine Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

List of Figure

List of Tables
Table 1. Major Company of Live Vaccines
Table 2. Major Company of Killed Vaccines
Table 3. Global Duck Virus Enteritis Vaccine Sales by Type 2018 VS 2022 VS 2029 (US$ Million)
Table 4. Global Duck Virus Enteritis Vaccine Sales by Type (2018-2024) & (M Units)
Table 5. Global Duck Virus Enteritis Vaccine Sales Market Share in Volume by Type (2018-2024)
Table 6. Global Duck Virus Enteritis Vaccine Sales by Type (2018-2024) & (US& Million)
Table 7. Global Duck Virus Enteritis Vaccine Market Share in Value by Type (2018-2024)
Table 8. Global Duck Virus Enteritis Vaccine Price by Type (2018-2024) & (USD/K Unit)
Table 9. Global Duck Virus Enteritis Vaccine Sales by Type (2024-2029) & (M Units)
Table 10. Global Duck Virus Enteritis Vaccine Sales Market Share in Volume by Type (2024-2029)
Table 11. Global Duck Virus Enteritis Vaccine Sales by Type (2024-2029) & (US$ Million)
Table 12. Global Duck Virus Enteritis Vaccine Sales Market Share in Value by Type (2024-2029)
Table 13. Global Duck Virus Enteritis Vaccine Price by Type (2024-2029) & (USD/K Unit)
Table 14. North America Duck Virus Enteritis Vaccine Sales by Type (2018-2024) & (M Units)
Table 15. North America Duck Virus Enteritis Vaccine Sales by Type (2018-2024) & (US$ Million)
Table 16. Europe Duck Virus Enteritis Vaccine Sales (M Units) by Type (2018-2024)
Table 17. Europe Duck Virus Enteritis Vaccine Sales by Type (2018-2024) & (US$ Million)
Table 18. Asia-Pacific Duck Virus Enteritis Vaccine Sales (M Units) by Type (2018-2024)
Table 19. Asia-Pacific Duck Virus Enteritis Vaccine Sales by Type (2018-2024) & (US$ Million)
Table 20. Latin America Duck Virus Enteritis Vaccine Sales (M Units) by Type (2018-2024)
Table 21. Latin America Duck Virus Enteritis Vaccine Sales by Type (2018-2024) & (US$ Million)
Table 22. Middle East and Africa Duck Virus Enteritis Vaccine Sales (M Units) by Type (2018-2024)
Table 23. Middle East and Africa Duck Virus Enteritis Vaccine Sales by Type (2018-2024) & (US$ Million)
Table 24. Global Duck Virus Enteritis Vaccine Sales by Company (2018-2024) & (M Units)
Table 25. Global Duck Virus Enteritis Vaccine Sales Share by Company (2018-2024)
Table 26. Global Duck Virus Enteritis Vaccine Revenue by Company (2018-2024) & (US$ Million)
Table 27. Global Duck Virus Enteritis Vaccine Revenue Share by Company (2018-2024)
Table 28. Global Market Duck Virus Enteritis Vaccine Price by Company (2018-2024) & (USD/K Unit)
Table 29. Global Duck Virus Enteritis Vaccine Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 30. Global Duck Virus Enteritis Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 31. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Duck Virus Enteritis Vaccine as of 2022)
Table 32. Date of Key Manufacturers Enter into Duck Virus Enteritis Vaccine Market
Table 33. Key Manufacturers Duck Virus Enteritis Vaccine Product Type
Table 34. Mergers & Acquisitions, Expansion Plans
Table 35. Global Duck Virus Enteritis Vaccine Market Size Comparison by Region (US$ Million): 2018 VS 2022 VS 2029
Table 36. Global Duck Virus Enteritis Vaccine Sales by Region (2018-2024) & (M Units)
Table 37. Global Duck Virus Enteritis Vaccine Sales Market Share in Volume by Region (2018-2024)
Table 38. Global Duck Virus Enteritis Vaccine Sales by Region (2018-2024) & (US$ Million)
Table 39. Global Duck Virus Enteritis Vaccine Sales Market Share in Value by Region (2018-2024)
Table 40. Global Duck Virus Enteritis Vaccine Sales (M Units), Revenue (US$ Million), Price (USD/K Unit) and Gross Margin (2018-2024)
Table 41. Global Duck Virus Enteritis Vaccine Sales by Region (2024-2029) & (M Units)
Table 42. Global Duck Virus Enteritis Vaccine Sales Market Share in Volume by Region (2024-2029)
Table 43. Global Duck Virus Enteritis Vaccine Sales by Region (2024-2029) & (US$ Million)
Table 44. Global Duck Virus Enteritis Vaccine Sales Market Share in Value by Region (2024-2029)
Table 45. Global Duck Virus Enteritis Vaccine Sales (M Units), Revenue (US$ Million), Price (USD/K Unit) and Gross Margin (2024-2029)
Table 46. Global Duck Virus Enteritis Vaccine Sales by Application: 2018 VS 2022 VS 2029 (US$ Million)
Table 47. Global Duck Virus Enteritis Vaccine Sales by Application (2018-2024) & (M Units)
Table 48. Global Duck Virus Enteritis Vaccine Sales Market Share in Volume by Application (2018-2024)
Table 49. Global Duck Virus Enteritis Vaccine Sales by Application (2018-2024) & (US$ Million)
Table 50. Global Duck Virus Enteritis Vaccine Sales Market Share in Value by Application (2018-2024)
Table 51. Global Duck Virus Enteritis Vaccine Price by Application (2018-2024) & (USD/K Unit)
Table 52. Global Duck Virus Enteritis Vaccine Sales by Application (2024-2029) & (M Units)
Table 53. Global Duck Virus Enteritis Vaccine Sales Market Share in Volume by Application (2024-2029)
Table 54. Global Duck Virus Enteritis Vaccine Sales by Application (2024-2029) & (US$ Million)
Table 55. Global Duck Virus Enteritis Vaccine Sales Market Share in Value by Application (2024-2029)
Table 56. Global Duck Virus Enteritis Vaccine Price by Application (2024-2029) & (USD/K Unit)
Table 57. North America Duck Virus Enteritis Vaccine Sales by Application (2018-2024) (M Units)
Table 58. North America Duck Virus Enteritis Vaccine Sales by Application (2018-2024) & (US$ Million)
Table 59. Europe Duck Virus Enteritis Vaccine Sales by Application (2018-2024) (M Units)
Table 60. Europe Duck Virus Enteritis Vaccine Sales by Application (2018-2024) & (US$ Million)
Table 61. Asia-Pacific Duck Virus Enteritis Vaccine Sales by Application (2018-2024) (M Units)
Table 62. Asia-Pacific Duck Virus Enteritis Vaccine Sales by Application (2018-2024) & (US$ Million)
Table 63. Latin America Duck Virus Enteritis Vaccine Sales by Application (2018-2024) (M Units)
Table 64. Latin America Duck Virus Enteritis Vaccine Sales by Application (2018-2024) & (US$ Million)
Table 65. Middle East and Africa Duck Virus Enteritis Vaccine Sales by Application (2018-2024) (M Units)
Table 66. Middle East and Africa Duck Virus Enteritis Vaccine Sales by Application (2018-2024) & (US$ Million)
Table 67. North America Duck Virus Enteritis Vaccine Sales by Country (2018-2024) & (M Units)
Table 68. North America Duck Virus Enteritis Vaccine Sales Market Share in Volume by Country (2018-2024)
Table 69. North America Duck Virus Enteritis Vaccine Sales by Country (2018-2024) & (US$ Million)
Table 70. North America Duck Virus Enteritis Vaccine Sales Market Share in Value by Country (2018-2024)
Table 71. North America Duck Virus Enteritis Vaccine Sales by Country (2024-2029) & (M Units)
Table 72. North America Duck Virus Enteritis Vaccine Sales Market Share in Volume by Country (2024-2029)
Table 73. North America Duck Virus Enteritis Vaccine Sales by Country (2024-2029) & (US$ Million)
Table 74. North America Duck Virus Enteritis Vaccine Sales Market Share in Value by Country (2024-2029)
Table 75. Europe Duck Virus Enteritis Vaccine Sales by Country (2018-2024) & (M Units)
Table 76. Europe Duck Virus Enteritis Vaccine Sales Market Share in Volume by Country (2018-2024)
Table 77. Europe Duck Virus Enteritis Vaccine Sales by Country (2018-2024) & (US$ Million)
Table 78. Europe Duck Virus Enteritis Vaccine Sales Market Share in Value by Country (2018-2024)
Table 79. Europe Duck Virus Enteritis Vaccine Sales by Country (2024-2029) & (M Units)
Table 80. Europe Duck Virus Enteritis Vaccine Sales Market Share in Volume by Country (2024-2029)
Table 81. Europe Duck Virus Enteritis Vaccine Sales by Country (2024-2029) & (US$ Million)
Table 82. Europe Duck Virus Enteritis Vaccine Sales Market Share in Value by Country (2024-2029)
Table 83. Asia-Pacific Duck Virus Enteritis Vaccine Sales by Region (2018-2024) & (M Units)
Table 84. Asia-Pacific Duck Virus Enteritis Vaccine Sales Market Share in Volume by Region (2018-2024)
Table 85. Asia-Pacific Duck Virus Enteritis Vaccine Sales by Region (2018-2024) & (US$ Million)
Table 86. Asia-Pacific Duck Virus Enteritis Vaccine Sales Market Share in Value by Region (2018-2024)
Table 87. Asia-Pacific Duck Virus Enteritis Vaccine Sales by Region (2024-2029) & (M Units)
Table 88. Asia-Pacific Duck Virus Enteritis Vaccine Sales Market Share in Volume by Region (2024-2029)
Table 89. Asia-Pacific Duck Virus Enteritis Vaccine Sales by Region (2024-2029) & (US$ Million)
Table 90. Asia-Pacific Duck Virus Enteritis Vaccine Sales Market Share in Value by Region (2024-2029)
Table 91. Latin America Duck Virus Enteritis Vaccine Sales by Country (2018-2024) & (M Units)
Table 92. Latin America Duck Virus Enteritis Vaccine Sales Market Share in Volume by Country (2018-2024)
Table 93. Latin America Duck Virus Enteritis Vaccine Sales by Country (2018-2024) & (US$ Million)
Table 94. Latin America Duck Virus Enteritis Vaccine Sales Market Share in Value by Country (2018-2024)
Table 95. Latin America Duck Virus Enteritis Vaccine Sales by Country (2024-2029) & (M Units)
Table 96. Latin America Duck Virus Enteritis Vaccine Sales Market Share in Volume by Country (2024-2029)
Table 97. Latin America Duck Virus Enteritis Vaccine Sales by Country (2024-2029) & (US$ Million)
Table 98. Latin America Duck Virus Enteritis Vaccine Sales Market Share in Value by Country (2024-2029)
Table 99. Middle East and Africa Duck Virus Enteritis Vaccine Sales by Country (2018-2024) & (M Units)
Table 100. Middle East and Africa Duck Virus Enteritis Vaccine Sales Market Share in Volume by Country (2018-2024)
Table 101. Middle East and Africa Duck Virus Enteritis Vaccine Sales by Country (2018-2024) & (US$ Million)
Table 102. Middle East and Africa Duck Virus Enteritis Vaccine Sales Market Share in Value by Country (2018-2024)
Table 103. Middle East and Africa Duck Virus Enteritis Vaccine Sales by Country (2024-2029) & (M Units)
Table 104. Middle East and Africa Duck Virus Enteritis Vaccine Sales Market Share in Volume by Country (2024-2029)
Table 105. Middle East and Africa Duck Virus Enteritis Vaccine Sales by Country (2024-2029) & (US$ Million)
Table 106. Middle East and Africa Duck Virus Enteritis Vaccine Sales Market Share in Value by Country (2024-2029)
Table 107. Ceva Santé Animale Company Information
Table 108. Ceva Santé Animale Introduction and Business Overview
Table 109. Ceva Santé Animale Duck Virus Enteritis Vaccine Sales (M Units), Revenue (Million USD), Price (USD/K Unit) and Gross Margin (2018-2024)
Table 110. Ceva Santé Animale Duck Virus Enteritis Vaccine Product
Table 111. Ceva Santé Animale Recent Development
Table 112. Chengdu TECBOND Biological Company Information
Table 113. Chengdu TECBOND Biological Introduction and Business Overview
Table 114. Chengdu TECBOND Biological Duck Virus Enteritis Vaccine Sales (M Units), Revenue (Million USD), Price (USD/K Unit) and Gross Margin (2018-2024)
Table 115. Chengdu TECBOND Biological Duck Virus Enteritis Vaccine Product
Table 116. Chengdu TECBOND Biological Recent Development
Table 117. Institute of Animal Health and Veterinary Biologicals Company Information
Table 118. Institute of Animal Health and Veterinary Biologicals Introduction and Business Overview
Table 119. Institute of Animal Health and Veterinary Biologicals Duck Virus Enteritis Vaccine Sales (M Units), Revenue (Million USD), Price (USD/K Unit) and Gross Margin (2018-2024)
Table 120. Institute of Animal Health and Veterinary Biologicals Duck Virus Enteritis Vaccine Product
Table 121. Institute of Animal Health and Veterinary Biologicals Recent Development
Table 122. Institute of Veterinary Preventive Medicine Company Information
Table 123. Institute of Veterinary Preventive Medicine Introduction and Business Overview
Table 124. Institute of Veterinary Preventive Medicine Duck Virus Enteritis Vaccine Sales (M Units), Revenue (Million USD), Price (USD/K Unit) and Gross Margin (2018-2024)
Table 125. Institute of Veterinary Preventive Medicine Duck Virus Enteritis Vaccine Product
Table 126. Institute of Veterinary Preventive Medicine Recent Development
Table 127. International Duck Research Cooperative Company Information
Table 128. International Duck Research Cooperative Introduction and Business Overview
Table 129. International Duck Research Cooperative Duck Virus Enteritis Vaccine Sales (M Units), Revenue (Million USD), Price (USD/K Unit) and Gross Margin (2018-2024)
Table 130. International Duck Research Cooperative Duck Virus Enteritis Vaccine Product
Table 131. International Duck Research Cooperative Recent Development
Table 132. MSD Animal Health (Merck) Company Information
Table 133. MSD Animal Health (Merck) Introduction and Business Overview
Table 134. MSD Animal Health (Merck) Duck Virus Enteritis Vaccine Sales (M Units), Revenue (Million USD), Price (USD/K Unit) and Gross Margin (2018-2024)
Table 135. MSD Animal Health (Merck) Duck Virus Enteritis Vaccine Product
Table 136. MSD Animal Health (Merck) Recent Development
Table 137. Ringpu (Tianjin)Bio-Pharmacy Company Information
Table 138. Ringpu (Tianjin)Bio-Pharmacy Introduction and Business Overview
Table 139. Ringpu (Tianjin)Bio-Pharmacy Duck Virus Enteritis Vaccine Sales (M Units), Revenue (Million USD), Price (USD/K Unit) and Gross Margin (2018-2024)
Table 140. Ringpu (Tianjin)Bio-Pharmacy Duck Virus Enteritis Vaccine Product
Table 141. Ringpu (Tianjin)Bio-Pharmacy Recent Development
Table 142. Veterinary Research Institute Company Information
Table 143. Veterinary Research Institute Introduction and Business Overview
Table 144. Veterinary Research Institute Duck Virus Enteritis Vaccine Sales (M Units), Revenue (Million USD), Price (USD/K Unit) and Gross Margin (2018-2024)
Table 145. Veterinary Research Institute Duck Virus Enteritis Vaccine Product
Table 146. Veterinary Research Institute Recent Development
Table 147. Key Raw Materials Lists
Table 148. Raw Materials Key Suppliers Lists
Table 149. Duck Virus Enteritis Vaccine Market Trends
Table 150. Duck Virus Enteritis Vaccine Market Drivers
Table 151. Duck Virus Enteritis Vaccine Market Challenges
Table 152. Duck Virus Enteritis Vaccine Market Restraints
Table 153. Duck Virus Enteritis Vaccine Distributors List
Table 154. Duck Virus Enteritis Vaccine Downstream Customers
Table 155. Research Programs/Design for This Report
Table 156. Key Data Information from Secondary Sources
Table 157. Key Data Information from Primary Sources
List of Figures
Figure 1. Duck Virus Enteritis Vaccine Product Picture
Figure 2. Global Duck Virus Enteritis Vaccine Market Size, 2018 VS 2022 VS 2029 (US$ Million)
Figure 3. Global Duck Virus Enteritis Vaccine Market Size Status and Outlook (2018-2029) & (US$ Million)
Figure 4. Global Duck Virus Enteritis Vaccine Sales Status and Outlook (2018-2029) & (M Units)
Figure 5. Product Picture of Live Vaccines
Figure 6. Global Live Vaccines Sales YoY Growth (2018-2029) & (M Units)
Figure 7. Product Picture of Killed Vaccines
Figure 8. Global Killed Vaccines Sales YoY Growth (2018-2029) & (M Units)
Figure 9. Global Duck Virus Enteritis Vaccine Sales by Type (2018-2029) & (US$ Million)
Figure 10. Global Duck Virus Enteritis Vaccine Sales Market Share by Type in 2022 & 2029
Figure 11. North America Duck Virus Enteritis Vaccine Sales Market Share in Volume by Type in 2022
Figure 12. North America Duck Virus Enteritis Vaccine Sales Market Share in Value by Type in 2022
Figure 13. Europe Duck Virus Enteritis Vaccine Sales Market Share in Volume by Type in 2022
Figure 14. Europe Duck Virus Enteritis Vaccine Sales Market Share in Value by Type in 2022
Figure 15. Asia-Pacific Duck Virus Enteritis Vaccine Sales Market Share in Volume by Type in 2022
Figure 16. Asia-Pacific Duck Virus Enteritis Vaccine Sales Market Share in Value by Type in 2022
Figure 17. Latin America Duck Virus Enteritis Vaccine Sales Market Share in Volume by Type in 2022
Figure 18. Latin America Duck Virus Enteritis Vaccine Sales Market Share in Value by Type in 2022
Figure 19. Middle East and Africa Duck Virus Enteritis Vaccine Sales Market Share in Volume by Type in 2022
Figure 20. Middle East and Africa Duck Virus Enteritis Vaccine Sales Market Share in Value by Type in 2022
Figure 21. The 5 and 10 Largest Manufacturers in the World: Market Share by Duck Virus Enteritis Vaccine Sales in 2022
Figure 22. The 5 and 10 Largest Manufacturers in the World: Market Share by Duck Virus Enteritis Vaccine Revenue in 2022
Figure 23. Duck Virus Enteritis Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 24. Product Picture of Duck
Figure 25. Global Duck Sales YoY Growth (2018-2029) & (M Units)
Figure 26. Product Picture of Others
Figure 27. Global Others Sales YoY Growth (2018-2029) & (M Units)
Figure 28. Global Duck Virus Enteritis Vaccine Sales by Application (2018-2029) & (US$ Million)
Figure 29. Global Duck Virus Enteritis Vaccine Sales Market Share by Application in 2022 & 2029
Figure 30. North America Duck Virus Enteritis Vaccine Sales Market Share in Volume by Application in 2022
Figure 31. North America Duck Virus Enteritis Vaccine Sales Market Share in Value by Application in 2022
Figure 32. Europe Duck Virus Enteritis Vaccine Sales Market Share in Volume by Application in 2022
Figure 33. Europe Duck Virus Enteritis Vaccine Sales Market Share in Value by Application in 2022
Figure 34. Asia-Pacific Duck Virus Enteritis Vaccine Sales Market Share in Volume by Application in 2022
Figure 35. Asia-Pacific Duck Virus Enteritis Vaccine Sales Market Share in Value by Application in 2022
Figure 36. Latin America Duck Virus Enteritis Vaccine Sales Market Share in Volume by Application in 2022
Figure 37. Latin America Duck Virus Enteritis Vaccine Sales Market Share in Value by Application in 2022
Figure 38. Middle East and Africa Duck Virus Enteritis Vaccine Sales Market Share in Value by Application in 2022
Figure 39. Key Raw Materials Price
Figure 40. Duck Virus Enteritis Vaccine Manufacturing Cost Structure
Figure 41. Duck Virus Enteritis Vaccine Industrial Chain Analysis
Figure 42. Channels of Distribution
Figure 43. Distributors Profiles
Figure 44. Bottom-up and Top-down Approaches for This Report
Figure 45. Data Triangulation
Figure 46. Key Executives Interviewed